Titre:
  • Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
Auteur:Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE), Amanda; Mocroft, Peter; Reiss, Ole; Kirk, Cristina; Mussini, Enrico; Girardi, Philippe; Morlat, Christoph; Stephan, Stéphane; De Wit, Katja; Doerholt, Jade; Ghosn, Heiner H.C.; Bucher, Jens D; Lundgren, Geneviève; Chêne, José María; Miró, Hansjakob; Furrer,
Informations sur la publication:Clinical infectious diseases, 51, 5, page (611-619)
Statut de publication:Publié, 2010-09
Sujet CREF:Sciences bio-médicales et agricoles
Pathologie maladies infectieuses
MeSH keywords:AIDS-Related Opportunistic Infections -- epidemiology -- immunology -- prevention & control
Adult
Anti-HIV Agents -- administration & dosage
Antifungal Agents -- administration & dosage -- therapeutic use
CD4 Lymphocyte Count
Europe -- epidemiology
Female
HIV Infections -- complications -- drug therapy -- immunology
Humans
Incidence
Male
Middle Aged
Pneumocystis jirovecii
Pneumonia, Pneumocystis -- epidemiology -- immunology -- prevention & control
Risk Factors
Langue:Anglais
Identificateurs:urn:issn:1058-4838
info:doi/10.1086/655761
info:pmid/20645862